In our study, the mRNA levels of Foxp3, a marker for Treg, were markedly increased in AOM/DSS-treated rats, but the elevation was inhibited by RQ-15986 administration, which suggests that IDO-induced Treg was inhibited by RQ-15986 administration, contributing to antitumor immune response. This evidence concerns the gene IDO1 and infectious otitis media.